Kyle Jenne
EVP, Chf GL Pdt Str Ofcr · 3 filings · Latest: Apr 15, 2026
IONIS PHARMACEUTICALS INC
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
IONS | Kyle Jenne | EVP, Chf GL Pdt Str Ofcr | Apr 16, 2026 | Sale | $75.17 | 4,902 | $368.5K | 23,713 | |
IONS | Kyle Jenne | EVP, Chf GL Pdt Str Ofcr | Apr 15, 2026 | Option Exercise | $0.00 | 12,226 | — | 28,615 | |
IONS | Jenne Kyle | — | Apr 16, 2026 | Proposed Sale | $75.40 | 4,902 | $369.6K | — | |
IONS | Kyle Jenne | EVP, Chf GL Pdt Str Ofcr | Mar 10, 2026 | Sale | $75.85 | 37,277 | $2.8M | 11,714 | |
IONS | Kyle Jenne | EVP, Chf GL Pdt Str Ofcr | Mar 10, 2026 | Option Exercise | $44.67 | 37,277 | $1.7M | 16,389 | |
IONS | Jenne Kyle | — | Mar 10, 2026 | Proposed Sale | $75.57 | 58,253 | $4.4M | — | |
IONS | Kyle Jenne | EVP, Chf GL Pdt Str Ofcr | Jan 16, 2026 | Sale | $75.96 | 1,823 | $138.5K | 16,389 | |
IONS | Kyle Jenne | EVP, Chf GL Pdt Str Ofcr | Jan 15, 2026 | Option Exercise | $0.00 | 7,013 | — | 18,212 | |
IONS | Jenne Kyle | — | Jan 16, 2025 | Proposed Sale | $76.23 | 1,823 | $139.0K | — | |
IONS | Jenne Kyle | — | Apr 16, 2025 | Proposed Sale | $28.36 | 3,016 | $85.5K | — |